The Gates Foundation will invest $100 million in grants to fight the new coronavirus epidemic

category:Internet
 The Gates Foundation will invest $100 million in grants to fight the new coronavirus epidemic


The bill and Melinda Gates Foundation today (5) announced a commitment to invest up to $100 million in grants to support the global response to the 2019 new coronavirus (2019 ncov) epidemic. The money will help strengthen case detection, isolation and treatment, protect vulnerable populations and accelerate the development of vaccines, drugs and diagnostic methods. The total amount of newly announced grants includes $10 million that the foundation has committed to fight the epidemic by the end of January.

Multilateral agencies, governments, the private sector and charities must work together to contain the epidemic, help countries protect the most vulnerable and accelerate the development of relevant tools. We want to invest more resources to help facilitate a rapid and effective international response, said Mark Sussman, CEO of the Gates Foundation. These responses should be guided by science, not fear, and based on measures taken by the World Health Organization.

The Gates Foundation, in close coordination with other donors, is contributing more resources to assist the World Health Organization, relevant institutions in China and other relevant institutions at the international and national levels. On January 30, the World Health Organization (who) announced that 2019 new coronavirus outbreak is a public health emergency of international concern, emphasizing the global risk of the virus, and called for a more coordinated global response, especially in countries and regions with fragile health systems. The Chinese government also declared the outbreak a major public health emergency and mobilized national forces to contain the spread of the epidemic.

Strengthen the detection, isolation and treatment of new coronavirus cases in 2019

The Gates Foundation will invest up to $20 million to speed up the detection, isolation and treatment of new coronavirus infections in order to block transmission and control the epidemic. The grant will be used to support multilateral agencies such as the World Health Organization, the Centers for Disease Control and prevention of the United States and public health departments of countries with confirmed cases, including the National Health Commission of China and the Centers for Disease Control and prevention of China.

The Foundation hopes to help multilateral agencies and national public health departments to quickly improve the virus detection capacity and implement disease transmission model analysis through fast and flexible funding, so as to accurately invest resources in the most serious epidemic areas and curb the spread of disease. The funds are intended to help the public health sector pay for early human and material costs in a timely manner in order to carry out its work quickly, while the resources allocated by international organizations and governments will be used to support the continuous operation of various works.

Strengthening the protection of vulnerable groups in Africa and South Asia

Epidemics in recent years, such as the 2009 H1N1 influenza epidemic, have had a significant impact on the extremely poor. It is estimated that 629 million people live on less than $1.90 a day globally, 85 per cent of whom live in sub Saharan Africa and South Asia. The lack of quality basic health care services for many residents in both regions further increases their health risks.

The Gates Foundation will provide up to $20 million to help public health departments in these areas improve their emergency operations, disease surveillance, and safe isolation and treatment of confirmed cases.

The work of the foundation in African Union Member States will be supported by the African Field Epidemiology Organization (AFENET), the African centers for Disease Control and prevention and the African Office of the World Health Organization. As a non-profit service alliance, the African Field Epidemiology organization is responsible for conducting field epidemiological research and laboratory training programs, which currently cover more than 30 African countries.

Develop vaccines, treatment and diagnostic tools to respond to the epidemic in the long run

The Gates Foundation will also provide up to $60 million to accelerate the identification, development and testing of new coronavirus vaccines, treatment and diagnostic tools in 2019. If the virus continues to spread in the coming months or even longer, only by finding a safe and effective vaccine and treatment program can we achieve long-term effective control of the epidemic and reduce cases and deaths. The Gates Foundation will use this R & D fund to support global partners such as the epidemic prevention Innovation Alliance (CEPI), identify needs and prioritize them, fill in the gaps in current R & D efforts, and motivate biotechnology and pharmaceutical companies to develop products, so as to bring safe, effective, affordable and wide coverage of pharmaceutical products. The foundation will also continue to support public and private sector R & D partners in China to identify, develop and test alternative vaccines, treatment options and diagnostics. At present, these works are in progress. Source: surging news editor: Wang Fengzhi, nt2541

The Gates Foundation will also provide up to $60 million to accelerate the identification, development and testing of new coronavirus vaccines, treatment and diagnostic tools in 2019. If the virus continues to spread in the coming months or even longer, only by finding a safe and effective vaccine and treatment program can we achieve long-term effective control of the epidemic and reduce cases and deaths.

The Gates Foundation will use this R & D fund to support global partners such as the epidemic prevention Innovation Alliance (CEPI), identify needs and prioritize them, fill in the gaps in current R & D efforts, and motivate biotechnology and pharmaceutical companies to develop products, so as to bring safe, effective, affordable and wide coverage of pharmaceutical products. The foundation will also continue to support public and private sector R & D partners in China to identify, develop and test alternative vaccines, treatment options and diagnostics. At present, these works are in progress.